Things to Keep in Mind Wegovy is preferred on most Aetna plans CVS Caremark made it their primary GLP-1 in July 2025 Prior authorization is required you'll need to meet BMI and documentation criteria If denied, file an appeal 65%+ of appealed denials are overturned when properly documented [5] Cardiovascular benefit strengthens your case Wegovy is FDA-approved to reduce heart attack/stroke risk (March 2024) If your PA is denied, don't give up most denials can be overturned with the right documentation
Serum prolactin concentration was elevated in most cases, probably due to pituitary stalk compression by the sellar tumor, the so-called stalk effect [15]
For example, one analysis found that patients taking a GLP-1 drug had a 3.67 times higher risk of gastroparesis compared to patients who took bupropion-naltrexone, a different weight-loss drug
Increasing evidence indicates 229,230 that IGFR, InsR, IRS1, Akt, GLUT4, and PPAR are more deacetylated in association with IR than in normal physiological conditions
Ask what happens to that figure if the dose changes
FGF, Fibroblast growth factor